1. Home
  2. SNSE vs EEIQ Comparison

SNSE vs EEIQ Comparison

Compare SNSE & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • EEIQ
  • Stock Information
  • Founded
  • SNSE 2005
  • EEIQ 2017
  • Country
  • SNSE United States
  • EEIQ United States
  • Employees
  • SNSE N/A
  • EEIQ N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • EEIQ Other Consumer Services
  • Sector
  • SNSE Health Care
  • EEIQ Real Estate
  • Exchange
  • SNSE Nasdaq
  • EEIQ Nasdaq
  • Market Cap
  • SNSE 10.8M
  • EEIQ 9.8M
  • IPO Year
  • SNSE 2021
  • EEIQ 2021
  • Fundamental
  • Price
  • SNSE $7.76
  • EEIQ $0.55
  • Analyst Decision
  • SNSE Strong Buy
  • EEIQ
  • Analyst Count
  • SNSE 4
  • EEIQ 0
  • Target Price
  • SNSE $72.50
  • EEIQ N/A
  • AVG Volume (30 Days)
  • SNSE 25.9K
  • EEIQ 351.6K
  • Earning Date
  • SNSE 08-05-2025
  • EEIQ 08-12-2025
  • Dividend Yield
  • SNSE N/A
  • EEIQ N/A
  • EPS Growth
  • SNSE N/A
  • EEIQ N/A
  • EPS
  • SNSE N/A
  • EEIQ N/A
  • Revenue
  • SNSE N/A
  • EEIQ $8,153,546.00
  • Revenue This Year
  • SNSE N/A
  • EEIQ N/A
  • Revenue Next Year
  • SNSE N/A
  • EEIQ N/A
  • P/E Ratio
  • SNSE N/A
  • EEIQ N/A
  • Revenue Growth
  • SNSE N/A
  • EEIQ 42.73
  • 52 Week Low
  • SNSE $5.00
  • EEIQ $0.42
  • 52 Week High
  • SNSE $17.40
  • EEIQ $1.19
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 52.43
  • EEIQ 44.54
  • Support Level
  • SNSE $6.33
  • EEIQ $0.60
  • Resistance Level
  • SNSE $10.99
  • EEIQ $0.68
  • Average True Range (ATR)
  • SNSE 1.00
  • EEIQ 0.05
  • MACD
  • SNSE 0.12
  • EEIQ -0.01
  • Stochastic Oscillator
  • SNSE 41.04
  • EEIQ 10.69

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

Share on Social Networks: